Back to mobile site

UPDATE: Morgan Stanley Downgrades Core Laboratories (CLB) to Equalweight on Valuation

July 9, 2021 2:04 AM EDT Send to a Friend
(Updated - July 9, 2021 4:15 AM EDT)

Morgan Stanley analyst Connor Lynagh downgraded Core Laboratories (NYSE: CLB) from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login